VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistInsider
ScreenerThemes
Earnings
WatchlistInsider
FG
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
FGF&G Annuities & Life, Inc.
$28.81$3.9B
Overview & Verdict
Overview
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders
HomeStocksFGQuarterly Financials

F&G Annuities & Life, Inc. (FG) Quarterly Financials

120+ quarters historyFree accessUpdated daily

F&G Annuities & Life, Inc. (FG) quarterly income statement — complete revenue, gross profit & net income history

FG Income Statement

Income StatementBalance SheetCash FlowRatios
AnnualQuarterly
MetricQ1'26Q4'25Q3'25Q2'25Q1'25Q4'24Q3'24Q2'24Q1'24Q4'23Q3'23Q2'23Q1'23Q4'22Q3'22Q2'22Q4'21Q1'20Q4'19Q3'19
Revenue1.19B1.76B1.6B1.3B854M1.47B1.36B1.07B1.51B1.55B783M1.12B812M629M957M12M1.52B-335M563M455M
Revenue Growth %38.99%20.07%17.78%21.3%-43.63%-5.28%73.82%-4.36%86.58%146.74%----58.67%----155.83%366.82%2.48%
Medical Costs & Claims484M1.26B1.18B993M524M927M1.09B608M1.16B1.63B292M817M812M-27M570M-377M1.4B000
Medical Cost Ratio %40.78%71.67%73.67%76.15%61.36%63.06%80.46%56.56%76.63%105.15%37.29%72.69%100%-4.29%59.56%-3141.67%92.25%0%0%0%
Gross Profit703M500M422M311M330M543M266M467M354M-80M491M307M0656M387M389M118M-335M563M455M
Gross Margin %59.22%28.33%26.33%23.85%38.64%36.94%19.54%43.44%23.37%-5.15%62.71%27.31%0%104.29%40.44%3241.67%7.75%100%100%100%
Gross Profit Growth %113.03%-7.92%58.65%-33.4%-6.78%778.75%-45.82%52.12%--112.2%---455.93%----155.83%366.82%2.48%
Operating Expenses380M339M291M254M356M131M296M213M212M295M111M144M203M832M149M-93M-34M-6M282M391M
OpEx / Revenue %32.01%19.21%18.15%19.48%41.69%8.91%21.75%19.81%13.99%19.01%14.18%12.81%25%132.27%15.57%-775%-2.23%1.79%50.09%85.93%
Depreciation & Amortization0174M180M158M153M152M147M147M123M110M108M104M90M-22M82M80M65M00-64M
Combined Ratio %72.79%90.88%91.83%95.63%103.04%71.97%102.2%76.37%90.63%124.16%51.47%85.5%125%127.98%75.13%-3916.67%90.01%1.79%50.09%85.93%
Operating Income323M161M131M57M-26M412M-30M254M142M-375M380M163M-203M-176M238M482M152M-329M281M64M
Operating Margin %27.21%9.12%8.17%4.37%-3.04%28.03%-2.2%23.63%9.37%-24.16%48.53%14.5%-25%-27.98%24.87%4016.67%9.99%98.21%49.91%14.07%
Operating Income Growth %1342.31%-60.92%536.67%-77.56%-118.31%209.87%-107.89%55.83%169.95%-113.07%----215.79%----275%247.12%-18.99%
EBITDA364M335M311M215M127M564M117M401M265M-265M488M267M-113M-198M320M562M217M-329M281M0
EBITDA Margin %30.67%18.98%19.4%16.49%14.87%38.37%8.6%37.3%17.49%-17.07%62.32%23.75%-13.92%-31.48%33.44%4683.33%14.26%98.21%49.91%0%
Interest Expense41M41M42M41M40M38M36M28M30M26M24M25M22M6M6M9M8M000
Non-Operating Income-41M-41M-42M-41M-40M-38M-36M-28M-30M-26M-24M-25M-22M-6M-6M-9M-8M-329M281M0
Pretax Income323M161M131M57M-26M412M-30M254M142M-375M380M163M-203M-176M238M482M152M-337M273M56M
Pretax Margin %27.21%9.12%8.17%4.37%-3.04%28.03%-2.2%23.63%9.37%-24.16%48.53%14.5%-25%-27.98%24.87%4016.67%9.99%100.6%48.49%12.31%
Income Tax74M31M11M15M-5M85M-25M50M26M-76M74M33M-8M-76M51M97M31M1M48M9M
Effective Tax Rate %22.91%19.25%8.4%26.32%19.23%20.63%83.33%19.69%18.31%20.27%19.47%20.25%3.94%43.18%21.43%20.12%20.39%-0.3%17.58%16.07%
Net Income248M128M118M40M-21M327M-6M203M115M-299M306M130M-195M-100M187M385M121M-338M225M58M
Net Margin %20.89%7.25%7.36%3.07%-2.46%22.24%-0.44%18.88%7.59%-19.27%39.08%11.57%-24.01%-15.9%19.54%3208.33%7.95%100.9%39.96%12.75%
Net Income Growth %1280.95%-60.86%2066.67%-80.3%-118.26%209.36%-101.96%56.15%158.97%-199%----182.64%----307.36%244.23%18.37%
EPS (Diluted)1.780.890.850.26-0.202.50-0.081.550.85-2.412.451.04-1.56-0.80-0.393.501.15-1.621.020.27
EPS Growth %990%-64.4%1154.59%-83.23%-123.53%203.73%-103.29%49.04%154.49%-201.25%----169.57%----318.92%243.66%17.39%
EPS (Basic)1.830.930.860.26-0.202.58-0.081.600.90-2.412.471.04-1.56-0.80-0.393.501.15-1.621.010.26
Diluted Shares Outstanding139M139M139M134M126M131M124M131M130M124M125M125M125M125M110M110M105M213.16M213.56M216.54M